glp 1 and crohn's disease SAFETY CLINICAL EFFECTIVENESS OF GLP1 AGONISTS IN INFLAMMATORY BOWEL PATIENTS GLP-1 Medications: Reimagining the Treatment

A 2023 study of more than 17,000 patients published in the New England Journal of Medicine found that semaglutide reduced the risk of major cardiovascular events including heart attack, stroke and cardiovascular death by about 20% in overweight or obese adults who already have cardiovascular disease but not diabetes

MAXIMUM BIOAVAILABILITY: By using liposomal delivery technology to create our supplement, the absorption rate and bioavailability of the supplement are enhanced

Furthermore, a major drawback of GLP-1 agonist drugs is a high incidence of gastrointestinal problems, like nausea, vomiting, diarrhoea, and constipation

This amino acid also plays a key role in repairing damaged tissue, helps maintain a healthy gut by strengthening the cell barrier that prevents your intestines from becoming damaged, and helps transport nitrogen (a key element thats important for many different functions) around your body